In 1784 Ugandan children aged 9–23 months, one-fifth and one-half fractional doses of 17DD yellow fever vaccine were non-inferior to the full dose for seroconversion at 4 weeks (5-point margin); no difference for one-fifth and −0·17 for one-half vs full dose (per protocol).
RCTn = 1,784
Doshi et al. Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial